|
|
Bridging Heart Failure and Diabetes Care
Course of the Month - February 2026
|
|
Facebook
LinkedIn
E-Mail
|
(2856)
|
Course of the Month
February 2026
Each month, the American Association of Nurse Practitioners® (AANP) will offer a continuing education (CE) activity presented by experts from AANP Communities. For the first month that it is offered, the activity will be FREE and only available to AANP members. After the initial month has passed, the activity will become available to both AANP members and non-members for a fee (AANP members will pay a significantly discounted price). The featured activity will rotate each month, so be sure to complete the activity and earn your CE credit before the month ends to benefit from free access!
Are you interested in this activity but not yet an AANP member? Becoming an AANP member can help you save on the purchase of this course and others — and it will provide you a full year of access to exclusive member benefits. Learn more about AANP membership and consider becoming a member today!
Promotional
Content Expires: | February 28, 2026 (11:55 p.m. CT) | | Content Expires: | January 31, 2027 (11:55 p.m. CT)
CE for this activity will not be available after this date. |
 | This activity includes closed captioning. |
This activity is free for AANP members from 2/1/2026 - 2/28/2026 |
Overview  This presentation examines the bidirectional relationship between heart failure and diabetes, emphasizing cardiovascular risk reduction through evidence-based pharmacologic strategies. It reviews the pathophysiology of HFrEF and HFpEF and highlights the role of SGLT2 inhibitors and GLP-1 receptor agonists in improving heart failure and cardiovascular outcomes, with or without diabetes. Key clinical trials—including DAPA-HF, EMPEROR-Preserved, EMPA-REG, SELECT, and STEP-HF—demonstrate reductions in heart failure hospitalizations, major adverse cardiovascular events, and symptom burden, alongside benefits in weight, renal function, and inflammation. The session differentiates drug classes with proven cardiovascular benefit from those with neutral or adverse effects and integrates current ADA guideline recommendations. Case studies illustrate real-world decision-making, safety considerations, and interprofessional collaboration when applying diabetes therapies to patients with heart failure.
Objectives
- Explain the pathophysiologic relationship between heart failure and type 2 diabetes and how this impacts drug selection.
- Review the mechanisms of action and cardiovascular effects of SGLT2 inhibitors and GLP-1 receptor agonists, including their role in patients with heart failure.
- Summarize evidence from major outcome trials, including EMPEROR, EMPA-REG, EMPULSE, DAPA-HF, DELIVER, SELECT, and the STEP-UP program, focusing on cardiovascular and heart failure endpoints.
- Differentiate drug classes that provide cardiovascular and heart failure benefit (SGLT2 inhibitors, GLP-1 receptor agonists) from those with neutral or adverse outcomes.
- Apply guideline-directed recommendations that integrate findings from trials into the management of patients with and without diabetes.
- Identify safety, monitoring, and interprofessional collaboration strategies when initiating or combining therapy traditionally used only for diabetes in patients with heart failure.
Speakers
Jane Kapustin, PhD, ANP-BC, BC-ADM, FAAN, FAANP
Ben Hocutt, DNP, AGACNP-BC, AACC, HF-Cert
Shannon Idzik, DNP, ANP-BC, FAAN, FAANP
Disclosure This program was planned in accordance with AANP CE Standards and Policies.
Speaker Disclosures:
- Benjamin Hocutt
- Speaker bureau for Kestra and scPharma (Heart Failure)
- Shannon Idzik
- Jane Kapustin
- Speaker bureau for Sanofi (T-Zield, type 1 diabetes)
- Speaker bureau for Simplicity Cequr (insulin delivery device)
- Advisory board for Madrigal (MASH)
DisclaimerIndividuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
- Read this activity description, including objectives and disclosures.
- Complete all educational content:
- Video Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
- Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
- After completing all educational content, go to the Next Steps button:
- Submit the activity evaluation to receive full AANP CE/Rx credit.
- Click on the Get Certificate button.
- A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
- A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information
For questions or more information concerning this online CE activity, please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
1.25 Contact Hour(s) of CE,
0.75 of which may be applied towards Pharmacology
|
|
Additional CE activities of interest
(OnDemand)
Obesity and Menopause: Improving Outcomes
(OnDemand)
Managing Insomnia
(OnDemand)
Migraine, Diagnosis and Treatment Tried, True and New
(OnDemand)
Lifestyle Medicine: A Solution to the Chronic Disease Epidemic
(OnDemand)
2025 Syphilis Update: What You Need to Know
(OnDemand)
Acute Kidney Injury and Chronic Kidney Disease: Guideline Updates
(OnDemand)
Diabetes and the Eye
(OnDemand)
Optimizing Midlife Health of Women
(OnDemand)
A Focus on Men’s Health: Erectile Dysfunction and Testosterone Deficiency
(OnDemand)
Osteoporosis Management and Fracture Prevention
(OnDemand)
A Systematic Approach to the Diagnosis and Management of Abnormal Uterine Bleeding
(OnDemand)
Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers
|
|
Adding Registration, Please wait...
